Trials / Active Not Recruiting
Active Not RecruitingNCT07145905
TCRM for Correction of Cheek Including Fine Lines
A Prospective, Open-label, Multicenter, Interventional Study, to Evaluate Safety and Efficacy of TCRM in the Treatment of the Cheek Area Including Fine Lines: SPARKS
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Teoxane SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical study is to evaluate benefits and risks of injecting TCRM in the cheek including fine lines. The goal is to show that treatment with TCRM will result in correcting the cheek area including the fine lines at 4 weeks after last treatment (initial injection or touch up) on subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TCRM | N=128 |
Timeline
- Start date
- 2023-11-30
- Primary completion
- 2025-09-30
- Completion
- 2026-01-31
- First posted
- 2025-08-28
- Last updated
- 2025-09-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT07145905. Inclusion in this directory is not an endorsement.